Sol-Gel Technologies (SLGL) Enterprise Value (2016 - 2025)
Sol-Gel Technologies (SLGL) reported Enterprise Value of -$11.0 million for Q4 2025, up 43.42% year-over-year from -$7.7 million in Q4 2024, and down 64.55% on a QoQ basis from -$6.7 million in Q3 2025.
Sol-Gel Technologies (SLGL) has 10 years of Enterprise Value data on file, last reported at -$11.0 million in Q4 2025.
- Quarterly Enterprise Value rose 43.42% year-over-year to -$11.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$11.0 million (up 43.42% YoY) and the FY2025 annual result came in at -$11.0 million, up 43.42% from the prior year.
- Enterprise Value fell to -$11.0 million in Q4 2025 per SLGL's latest filing, from -$6.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$5.8 million in Q2 2022 and bottomed at -$43.3 million in Q3 2021.
- The 5-year median for Enterprise Value is -$13.0 million (2021), against an average of -$15.5 million.
- The widest annual swing landed in 2021, when Enterprise Value sank 621.64%; it then soared 80.39% in 2022.
- Tracing SLGL's Enterprise Value over 5 years: stood at -$21.8 million in 2021, then advanced by 3.07% to -$21.1 million in 2022, then tumbled by 32.46% to -$28.0 million in 2023, then soared by 30.31% to -$19.5 million in 2024, then jumped by 43.42% to -$11.0 million in 2025.
- Per Business Quant, the three latest SLGL Enterprise Value figures stand at -$11.0 million (Q4 2025), -$6.7 million (Q3 2025), and -$10.2 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Sol-Gel Technologies | 205.76 Mn | 194.73 Mn | - | -11.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.03 Mn |
| Sep 30, 2025 | -6.71 Mn |
| Jun 30, 2025 | -10.22 Mn |
| Mar 31, 2025 | -16.89 Mn |
| Dec 31, 2024 | -19.50 Mn |
| Sep 30, 2024 | -13.42 Mn |
| Jun 30, 2024 | -11.55 Mn |
| Mar 31, 2024 | -11.21 Mn |
| Dec 31, 2023 | -27.98 Mn |
| Sep 30, 2023 | -14.14 Mn |
| Jun 30, 2023 | -15.62 Mn |
| Mar 31, 2023 | -6.81 Mn |
| Dec 31, 2022 | -21.13 Mn |
| Sep 30, 2022 | -8.50 Mn |
| Jun 30, 2022 | -5.77 Mn |
| Mar 31, 2022 | -21.25 Mn |
| Dec 31, 2021 | -21.79 Mn |
| Sep 30, 2021 | -43.35 Mn |
| Jun 30, 2021 | -11.15 Mn |
| Mar 31, 2021 | -12.65 Mn |
| Dec 31, 2020 | -28.77 Mn |
| Sep 30, 2020 | -6.01 Mn |
| Jun 30, 2020 | -5.44 Mn |
| Mar 31, 2020 | -2.20 Mn |
| Dec 31, 2019 | -50.38 Mn |
| Sep 30, 2019 | -7.64 Mn |
| Jun 30, 2019 | -14.39 Mn |
| Mar 31, 2019 | -8.18 Mn |
| Dec 31, 2018 | -61.99 Mn |
| Sep 30, 2018 | -13.27 Mn |
| Jun 30, 2018 | -18.24 Mn |
| Mar 31, 2018 | -79.80 Mn |
| Dec 31, 2017 | -5.02 Mn |
| Dec 31, 2016 | -7.00 Mn |